Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06177977 · ClinicalTrials.gov registry record · NA
SS-HH-OCT as a Novel Diagnostic Modality for Early-Onset Retinal Dystrophies (EORDs)
A NA study of Retinal Dystrophies, sponsored by Duke University.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT06177977 is a NA study of Retinal Dystrophies that is actively recruiting participants, run by Duke University. The registered enrollment target is 80 participants, below the 129-participant average among 10 other Retinal Dystrophies trials with a reported enrollment target (38% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06177977, a NA study of Retinal Dystrophies, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational study is to utilize a novel imaging system designed for high-resolution retinal imaging of neonates, infants and children to identify the signs of photoreceptor development and degeneration in children with early-onset inherited retinal dystrophies (EORDs). Participants will have research imaging with SS-HH-OCT at the time of clinically-indicated eye examinations or procedures. The investigators aim to establish the basis for utilization of OCT imaging in earlier diagnosis and disease monitoring in children with EORDs. This work will set data reference standards and IRD endpoints that can be used in clinical trials.
Conditions Studied
Interventions
- DEVICE SS-HH-OCT
Study Locations (1)
North Carolina
- Duke University Eye Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2024-03-01 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06177977
The ClinicalTrials.gov registry entry for NCT06177977 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 129-participant average among 10 other Retinal Dystrophies trials with a reported enrollment target (38% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Retinal Dystrophies appearing as the primary indexed condition, and to 1 intervention - of which SS-HH-OCT is the first listed.
NCT06177977 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT06177977 about?
NCT06177977 is a clinical study titled "SS-HH-OCT as a Novel Diagnostic Modality for Early-Onset Retinal Dystrophies (EORDs)". The goal of this observational study is to utilize a novel imaging system designed for high-resolution retinal imaging of neonates, infants and children to identify the signs of photoreceptor development and degeneration in children with early-onset inherited retinal dystrophies (EORDs). Participant...
What is the current status of trial NCT06177977?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2024-03-01. Estimated completion is 2026-12.
What conditions does trial NCT06177977 study?
This clinical trial studies the following conditions: Retinal Dystrophies.
What interventions are being tested in trial NCT06177977?
The interventions under investigation include: SS-HH-OCT (DEVICE).
Who is sponsoring clinical trial NCT06177977?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06177977 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Retinal Dystrophies
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Optical Head-Mounted Display Technology for Low Vision Rehabilitation
COMPLETED · NA
-
Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degeneration
RECRUITING
-
A Repeat-Dose, Open-Label, Two Arm Safety and Efficacy Study of Two Doses of VP-001 Administered Intravitreally in Participants With Confirmed PRPF31 Mutation-Associated Retinal Dystrophy, Including Participants Previously Treated With VP001
RECRUITING · Phase 1
-
EyeConic: Qualification for Cone-Optogenetics
RECRUITING
-
The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration
RECRUITING · Phase 1
-
MAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects (Wallaby)
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.